-The Indian Express From Nariman Point to Tirupur, from broking firms to ancillary industries — as a two-part series in this newspaper has illustrated — the economy is seeing a steady contraction in employment opportunities. The economic and social cost is sobering but the UPA should also worry about the political implications. Lakhs of jobs are being lost when India is heading for a general election that could be decided primarily...

-The Times of India The Prime Minister's Office (PMO) has sounded an alert over a deficient monsoon, directing ministries to help states facing drought-like situations by operationalizing contingency plans to distribute seeds, augment fodder and power and deal with drinking water shortages. PMO said the monsoon season rainfall is likely to be 92% of the long-term average (LPA), less than the 96% LPA predicted in June that itself was a downgrade from...

-The Economic Times This year's frail monsoon has depleted Indian reservoirs to alarming levels last seen during the devastating drought of 2009, threatening even winter-sown crops and making the country vulnerable to drinking water scarcity by February as India's grossly inadequate storage capacity magnifies the impact of weak rainfall. The situation is precarious because the monsoon has delivered normal rainfall to only one-third of the country. The total deficit so far this...

-The Guardian Higher disposable incomes, changing consumption patterns and the marketing might of powerful western brands are bringing fast food to India's children The camera pans in. The grins of smiling school children fill the frame. An enthusiastic teacher, played by a famous Bollywood actress, sits in the centre. The scene is a "remote picturesque setting". And all are munching happily on Domino's Pizza. The advert is typical of the marketing bombardment...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...